GLP-2 is our catalogue designation for a dual GIP and GLP-1 receptor agonist supplied in lyophilised form across seven vial strengths. The dual-incretin mechanism is what distinguishes it from single-receptor comparators in metabolic research.
Product Specifications:
- Purity: ≥99% (HPLC Verified)
- Form: Lyophilized Powder
- Unit Size: 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, 60mg per vial
- Storage: Store at -20°C or lower
- Usage: Laboratory research use only
Research Applications:
Work with this compound typically addresses:
- Dual GIP/GLP-1 receptor co-activation
- Glucose-dependent insulin secretion assays
- Adipose and hepatic metabolic signalling
- Comparative incretin pharmacology
Note: Research compound for in vitro laboratory use. Not a medicine and not approved for human or veterinary administration.
Questions about specifications or certificates of analysis? Send them through our contact form.
Purity: ≥99% (HPLC verified)
Form: Lyophilised powder
Storage: Store at −20°C or lower
Reconstitution: Bacteriostatic water (sold separately)
Usage: Laboratory research use only